Protein C
Top View
- Activated Human Protein C Prevents Thrombin-Induced Thromboembolism in Mice. Evidence That Activated Protein C Reduces Intravasc
- Hypercoagulability Syndromes
- Severe Factor XII Deficiency with Unusual Presentation During Pregnancy: a Case Report
- Canonical and Non-Canonical Reelin Signaling
- Prediction of Proprotein Convertase Cleavage Sites
- Basic Sciences
- Small-Intestinal Dysfunction Accompanies the Complex Endocrinopathy of Human Proprotein Convertase 1 Deficiency
- SARS-Cov-2 Growth, Furin-Cleavage-Site Adaptation and Neutralization Using Serum from Acutely Infected, Hospitalized COVID-19 Patients
- Heparin Binding to Protein C Inhibitor
- Antithrombotic, Procoagulant, and Fibrinolytic Mechanisms in Cerebral Circulation: Implications for Brain Injury and Protection
- Role of the Activation Peptide in the Mechanism of Protein C Activation Bosko M
- Activated Protein C Ligation of Apoer2 (LRP8) Causes Dab1-Dependent Signaling in U937 Cells
- Variation of Complement Factor H and Mannan Binding Lectin in Human
- (12) United States Patent (10) Patent No.: US 6,403,556 B1 Eibl Et Al
- Targeted Inhibition of Activated Protein C by a Non-Active-Site Inhibitory
- Human Plasma Protein C: ISOLATION, CHARACTERIZATION, and MECHANISM of ACTIVATION by Α-THROMBIN
- Protein C Concentrate (Human)]
- CEPROTIN [Protein C Concentrate (Human)] Lyophilized Powder None